DNA Methylation in Ovarian Cancer
Author Information
Author(s): Wu Qinghua, Lothe Ragnhild A, Ahlquist Terje, Silins Ilvars, Tropé Claes G, Micci Francesca, Nesland Jahn M, Suo Zhenhe, Lind Guro E
Primary Institution: Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo
Hypothesis
The study investigates the promoter methylation status of 13 genes in ovarian carcinomas and their in vitro models.
Conclusion
DNA hypermethylation of tumour suppressor genes plays an important role in ovarian carcinogenesis, identifying HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Supporting Evidence
- 40 out of 52 tumours were methylated in one or more genes.
- Hypermethylation of HOXA9 was more common in early-stage carcinomas.
- Methylation frequencies were higher in older patients.
Takeaway
The study found that certain genes are often turned off in ovarian cancer due to a process called methylation, which can help us understand and potentially detect the disease earlier.
Methodology
The study used methylation-specific polymerase chain reaction (MSP) and direct bisulphite sequencing to analyze the methylation status of genes in ovarian carcinomas and cell lines.
Limitations
The study did not include normal ovarian samples for comparison.
Participant Demographics
The majority of patients were older than 40 years, with a peak incidence at ages 75-79.
Statistical Information
P-Value
0.002, 0.020, 0.023, 0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website